400-921-8278
| Catalog_no | ADMC0224 |
| Product_name | Palbociclib (PD0332991 HCl) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 780.00/1120.00/1440.00 |
| Specificity | Target: CDK. Fields: Palbociclib is an oral, small molecule cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, now in Phase 3 clinical development for advanced breast cancer. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Dilution | IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Purification | >99% |
| Concentration | 靶点：CDK;IC50： 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | PD 0332991,PD-0332991 |
| Observed_band | 483.99 |
| Notes | Palbociclib is an oral, small molecule cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, now in Phase 3 clinical development for advanced breast cancer. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
